» Articles » PMID: 30813375

Ionic Liquids As Potential and Synergistic Permeation Enhancers for Transdermal Drug Delivery

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2019 Mar 1
PMID 30813375
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Transdermal drug delivery systems (TDDS) show clear advantages over conventional routes of drug administration. Nonetheless, there are limitations to current TDDS which warrant further research to improve current TDD platforms. Spurred by the synthesis of novel biodegradable ionic liquids (ILs) and favorable cytotoxicity studies, ILs were shown to be a possible solution to overcome these challenges. Their favorable application in overcoming challenges ranging from synthesis, manufacture, and even therapeutic benefits were documented. In this review, said ILs are highlighted and their role in TDDS is reviewed in terms of (a) ILs as permeation enhancers (single agents or combined), (b) ILs in drug modification, and (c) ILs as active pharmaceutical ingredients. Furthermore, future combination of ILs with other chemical permeation enhancers (CPEs) is proposed and discussed.

Citing Articles

Pioneering ionic liquids in neuro-soothing: Enhanced transdermal delivery of collagen peptides and their synergistic anti-aging functions.

Wang M, Wang Z, Liu T, Zhao Y, Sun X, Lu B Mater Today Bio. 2025; 31:101527.

PMID: 39968525 PMC: 11834113. DOI: 10.1016/j.mtbio.2025.101527.


Transdermal Insulin Delivery Using Ionic Liquid-Mediated Nanovesicles for Diabetes Treatment.

Nabila F, Islam R, Yamin L, Yoshirou K, Wakabayashi R, Kamiya N ACS Biomater Sci Eng. 2024; 11(1):402-414.

PMID: 39686755 PMC: 11808643. DOI: 10.1021/acsbiomaterials.4c02000.


Synthesis, Characterization, Bioavailability and Antimicrobial Studies of Cefuroxime-Based Organic Salts and Ionic Liquids.

Faisca F, Petrovski Z, Grilo I, Lima S, Santos M, Branco L Pharmaceutics. 2024; 16(10).

PMID: 39458620 PMC: 11510342. DOI: 10.3390/pharmaceutics16101291.


Design Principles and Applications of Ionic Liquids for Transdermal Drug Delivery.

Gao S, Cheng X, Zhang M, Dai Q, Liu C, Lu Y Adv Sci (Weinh). 2024; 11(43):e2405983.

PMID: 39342651 PMC: 11578336. DOI: 10.1002/advs.202405983.


An insight into pharmaceutical challenges with ionic liquids: where do we stand in transdermal delivery?.

Jain A, Shakya A, Prajapati S, Eldesoqui M, Mody N, Jain S Front Bioeng Biotechnol. 2024; 12:1454247.

PMID: 39165403 PMC: 11333206. DOI: 10.3389/fbioe.2024.1454247.


References
1.
Liu S, Jin M, Quan Y, Kamiyama F, Katsumi H, Sakane T . The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release. 2012; 161(3):933-41. DOI: 10.1016/j.jconrel.2012.05.030. View

2.
Williams A, Barry B . Penetration enhancers. Adv Drug Deliv Rev. 2004; 56(5):603-18. DOI: 10.1016/j.addr.2003.10.025. View

3.
Zakrewsky M, Lovejoy K, Kern T, Miller T, Le V, Nagy A . Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization. Proc Natl Acad Sci U S A. 2014; 111(37):13313-8. PMC: 4169946. DOI: 10.1073/pnas.1403995111. View

4.
Wang D, Richter C, Ruhling A, Drucker P, Siegmund D, Metzler-Nolte N . A Remarkably Simple Class of Imidazolium-Based Lipids and Their Biological Properties. Chemistry. 2015; 21(43):15123-6. DOI: 10.1002/chem.201502333. View

5.
Davis Jr J, Fox P . From curiosities to commodities: ionic liquids begin the transition. Chem Commun (Camb). 2003; (11):1209-12. View